Calithera Biosciences Finds $35M
South San Francisco-based Calithera Biosciences, a developer of cancer therapeutics, has raised $35M in its Series D funding round, the company announced. The company said the funding was led by Adage Capital Partners, and also included Longwood Fund, two un-named institutional investor groups, plus existing investors Morgenthaler Ventures, Advanced Technology Ventures and Delphi Ventures also participated. Longwood Fund's Christoph Westphal has joined the company's board as part of the funding. The company said the funding will go towards advancing its lead candidate through Phase 1 clinical trials.
posted on Wednesday, October 30, 2013 (Link to more information)
Related companies:
Calithera Biosciences
Related stories:
> Calithera Biosciences Sets IPO Pricing Range
> Calithera Biosciences Raises $40M
> 3-V Biosciences Finds $20M In Funding
> 3-V Biosciences Finds $20M
> Xcell Biosciences Finds $12M
silicontap.com Home